Results 161 to 170 of about 401,465 (309)

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

open access: yesScience Translational Medicine, 2014
M. Davila   +31 more
semanticscholar   +1 more source

Genetic alterations in myeloid sarcoma among acute myeloid leukemia patients: insights from 37 cohort studies and a meta-analysis

open access: yesFrontiers in Oncology
IntroductionVariations in mutation rates among acute myeloid leukemia (AML) patients with myeloid sarcoma (MS) underscore the need for a thorough examination. This meta-analysis was conducted to fill the information gap concerning mutation frequencies in
Suvijak Untaaveesup   +9 more
doaj   +1 more source

Long‐Term Follow‐up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

open access: yesNew England Journal of Medicine, 2018
Jae H. Park   +14 more
semanticscholar   +1 more source

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

open access: yesNew England Journal of Medicine, 2017
H. Kantarjian   +25 more
semanticscholar   +1 more source

Late multifocal gliomas in adolescents previously treated for acute lymphoblastic leukemia [PDF]

open access: bronze, 1987
Margherita Fontana   +7 more
openalex   +1 more source

A Diagnostic Model for Acute Lymphoblastic Leukemia Using Metaheuristics and Deep Learning Methods [PDF]

open access: yesarXiv
Acute lymphoblastic leukemia (ALL) severity is determined by the presence and ratios of blast cells (abnormal white blood cells) in both bone marrow and peripheral blood. Manual diagnosis of this disease is a tedious and time-consuming operation, making it difficult for professionals to accurately examine blast cell characteristics.
arxiv  

Home - About - Disclaimer - Privacy